FDA Requiring Labeling Changes for Opioid Pain Medicines, Opioid Use Disorder Medicines Regarding Naloxone

The U.S. Food and Drug Administration today announced it is requiring that labeling for opioid pain medicine and medicine to treat opioid use disorder (OUD) be updated to recommend that as a routine part of prescribing these medicines, health care professionals should discuss the availability of naloxone with patients and caregivers, both when beginning and renewing treatment.

Continue reading

(Scotland) Lord Advocate gives reassurance that naloxone supply can expand

On Sunday at a media briefing in Edinburgh, Health Secretary Jeane Freeman announced that “the Lord Advocate has confirmed that – for the duration of this crisis – it would not be in the public interest to prosecute any individual – working for a service registered with the Scottish Government – who supplies naloxone in an emergency, to save a life”. This development aims to increase the distribution of naloxone kits by relaxing the rules around who can supply the life-saving medication. It remains the case that anyone can legally administer naloxone, to anyone, for the purpose of responding to a suspected opiate-related overdose.

Continue reading

Brand new naloxone window stickers will be popping up across Scotland any day now!

The window clings with the well-known ‘save someone’ logo will be provided to local naloxone leads who will distribute to services in their health board area that have naloxone available for use in an emergency. Most of these services will have naloxone available to take home as well. The ‘save someone’ logo was established in 2012 and has been used by colleagues and agencies internationally to promote the life-saving medication.

Continue reading

This website has been made possible through the provision of an arm length/unrestricted educational grant from Ethypharm. Ethypharm do not control and are not liable for any of the content placed, or any of the claims that may be made, on this site.

HIT